Research statistics

Ziconotide research: publications and trials

What has been published on Ziconotide: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Ziconotide works or is safe. For what it is and what the studies found, see the Ziconotide profile.
Automated weekly refresh · data through November 1, 2026

At a glance

Publications, all years

380

Since 1987

Publications in 2026 so far

7

Through November 1, 2026

Human clinical research

22.3%

83 of 373 classified

Registered clinical trials

11

ClinicalTrials.gov

Randomized controlled trials

5

Publications reporting an RCT in people

Systematic reviews and meta-analyses

1

Preclinical studies

48.0%

137 animal · 40 in vitro · 2 computational

Records that only mention it

163

Not counted above

Status in the library: FDA-approved. 7 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Ziconotide publications by year and evidence

1987, Preclinical (animal, in vitro, computational): 1 of 11992, Preclinical (animal, in vitro, computational): 1 of 11993, Preclinical (animal, in vitro, computational): 2 of 21994, Preclinical (animal, in vitro, computational): 10 of 111994, Other and not yet classified: 1 of 111995, Preclinical (animal, in vitro, computational): 11 of 111996, Preclinical (animal, in vitro, computational): 6 of 81996, Other and not yet classified: 2 of 81997, Human clinical research: 2 of 171997, Preclinical (animal, in vitro, computational): 14 of 171997, Reviews and meta-analyses: 1 of 171998, Preclinical (animal, in vitro, computational): 9 of 131998, Reviews and meta-analyses: 1 of 131998, Other and not yet classified: 3 of 131999, Preclinical (animal, in vitro, computational): 7 of 101999, Reviews and meta-analyses: 1 of 101999, Other and not yet classified: 2 of 102000, Human clinical research: 3 of 232000, Preclinical (animal, in vitro, computational): 16 of 232000, Reviews and meta-analyses: 3 of 232000, Other and not yet classified: 1 of 232001, Human clinical research: 1 of 72001, Preclinical (animal, in vitro, computational): 5 of 72001, Reviews and meta-analyses: 1 of 72002, Human clinical research: 1 of 72002, Preclinical (animal, in vitro, computational): 5 of 72002, Reviews and meta-analyses: 1 of 72003, Human clinical research: 1 of 52003, Preclinical (animal, in vitro, computational): 4 of 52004, Human clinical research: 2 of 62004, Preclinical (animal, in vitro, computational): 2 of 62004, Reviews and meta-analyses: 1 of 62004, Other and not yet classified: 1 of 62005, Preclinical (animal, in vitro, computational): 5 of 192005, Reviews and meta-analyses: 4 of 192005, Other and not yet classified: 10 of 192006, Human clinical research: 6 of 212006, Preclinical (animal, in vitro, computational): 5 of 212006, Reviews and meta-analyses: 8 of 212006, Other and not yet classified: 2 of 212007, Human clinical research: 2 of 142007, Preclinical (animal, in vitro, computational): 7 of 142007, Reviews and meta-analyses: 3 of 142007, Other and not yet classified: 2 of 142008, Human clinical research: 6 of 232008, Preclinical (animal, in vitro, computational): 7 of 232008, Reviews and meta-analyses: 8 of 232008, Other and not yet classified: 2 of 232009, Human clinical research: 3 of 112009, Preclinical (animal, in vitro, computational): 5 of 112009, Reviews and meta-analyses: 3 of 112010, Human clinical research: 4 of 132010, Preclinical (animal, in vitro, computational): 5 of 132010, Reviews and meta-analyses: 3 of 132010, Other and not yet classified: 1 of 132011, Human clinical research: 7 of 142011, Preclinical (animal, in vitro, computational): 3 of 142011, Reviews and meta-analyses: 2 of 142011, Other and not yet classified: 2 of 142012, Human clinical research: 2 of 72012, Preclinical (animal, in vitro, computational): 3 of 72012, Reviews and meta-analyses: 2 of 72013, Human clinical research: 3 of 122013, Preclinical (animal, in vitro, computational): 5 of 122013, Reviews and meta-analyses: 3 of 122013, Other and not yet classified: 1 of 122014, Human clinical research: 4 of 102014, Preclinical (animal, in vitro, computational): 3 of 102014, Reviews and meta-analyses: 2 of 102014, Other and not yet classified: 1 of 102015, Human clinical research: 8 of 182015, Preclinical (animal, in vitro, computational): 8 of 182015, Reviews and meta-analyses: 2 of 182016, Human clinical research: 3 of 72016, Reviews and meta-analyses: 3 of 72016, Other and not yet classified: 1 of 72017, Human clinical research: 2 of 72017, Preclinical (animal, in vitro, computational): 1 of 72017, Reviews and meta-analyses: 4 of 72018, Human clinical research: 1 of 102018, Preclinical (animal, in vitro, computational): 3 of 102018, Reviews and meta-analyses: 4 of 102018, Other and not yet classified: 2 of 102019, Human clinical research: 4 of 112019, Preclinical (animal, in vitro, computational): 2 of 112019, Reviews and meta-analyses: 5 of 112020, Human clinical research: 5 of 152020, Preclinical (animal, in vitro, computational): 6 of 152020, Reviews and meta-analyses: 3 of 152020, Other and not yet classified: 1 of 152021, Human clinical research: 3 of 92021, Preclinical (animal, in vitro, computational): 4 of 92021, Reviews and meta-analyses: 2 of 92022, Human clinical research: 2 of 52022, Preclinical (animal, in vitro, computational): 2 of 52022, Other and not yet classified: 1 of 52023, Preclinical (animal, in vitro, computational): 3 of 42023, Reviews and meta-analyses: 1 of 42024, Human clinical research: 3 of 132024, Preclinical (animal, in vitro, computational): 4 of 132024, Reviews and meta-analyses: 4 of 132024, Other and not yet classified: 2 of 132025, Human clinical research: 3 of 82025, Preclinical (animal, in vitro, computational): 1 of 82025, Reviews and meta-analyses: 2 of 82025, Other and not yet classified: 2 of 82026 (to date), Human clinical research: 2 of 72026 (to date), Preclinical (animal, in vitro, computational): 4 of 72026 (to date), Reviews and meta-analyses: 1 of 7Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified010203019871999200720152026*
Counted PubMed publications by year of first publication. * 2026 runs to November 1, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
198701001
199201001
199302002
19940100111
19950110011
199606028
19972141017
1998091313
1999071210
20003163123
200115107
200215107
200314005
200422116
20050541019
2006658221
2007273214
2008678223
2009353011
2010453113
2011732214
201223207
2013353112
2014432110
2015882018
201630317
201721407
2018134210
2019425011
2020563115
202134209
202222015
202303104
2024344213
202531228
2026 (to date)24107

Study types

Animal study137
Review77
Case report42
In vitro study40
Editorial, letter or other29
Observational human study19
Other clinical trial17
Not yet classified7
Randomized controlled trial5
Guideline or consensus4
Computational study2
Systematic review1

Research areas

From MeSH major topics. A paper can be in several areas.

Neurological and mental health277
Cardiovascular25
Tissue repair21
Musculoskeletal15
Oncology15
Immune system6
Endocrinology5
Gastrointestinal5
Antimicrobial and infectious disease4
Reproductive and sexual health2
Cognitive health1
Metabolic health1

Registered clinical trials

2 of 4 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 6 · Recruiting: 2 · Not yet recruiting: 1 · Unknown status: 1 · Withdrawn: 1
Phase not applicable: 4 · Phase 2: 2 · Phase 3: 2 · Phase 4: 3

TrialStatusPhaseStartedResults
Intrathecal Ziconotide in Chemotherapy Induced Peripheral NeuropathyNCT07499882 · 24 enrolledNot yet recruitingPhase not applicable2026-05—
Ziconotide for Non-cancer Pain by Intrathecal AdministrationNCT06541184 · 85 enrolledRecruitingPhase not applicable2024-10—
OP2C : Prialt® Observatory in Clinical PracticeNCT04321408 · 300 enrolledRecruitingPhase not applicable2020-07—
Ziconotide as First-Line IDTNCT03321955 · 13 enrolledCompletedPhase 42016-11—
Single Shot Intrathecal Ziconotide for Painful Neuropathy or MyelopathyNCT01992562WithdrawnPhase 42014-01—
Patient Registry of Intrathecal Ziconotide Management(PRIZM)NCT01888120 · 93 enrolledCompletedPhase not applicable2013-07—
Intrathecal Bolus Doses of ZiconotideNCT01373983 · 26 enrolledCompletedPhase 42011-08—
Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With CancerNCT00996983 · 16 enrolledUnknown statusPhase 22009-09—
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe PainNCT00076544 · 300 enrolledCompletedPhase 32004-02—
Prialt (Ziconotide) In Severe Chronic PainNCT00047749 · 220 enrolledCompletedPhase 32002-08—
A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic PainNCT00002160 · 100 enrolledCompletedPhase 2——

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Ziconotide Monotherapy: A Systematic Review of Randomised Controlled Trials.

    Current neuropharmacology · January 1, 2017 · Systematic review · cited 61 times · open access

    PMID 26861472 · DOI 10.2174/1570159x14666160210142056 · Reviews and meta-analyses

  2. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

    Journal of pain and symptom management · May 1, 2006 · Randomized controlled trial · cited 306 times · open access

    PMID 16716870 · DOI 10.1016/j.jpainsymman.2005.10.003 · Human clinical research

  3. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial.

    Neuromodulation : journal of the International Neuromodulation Society · April 1, 2006 · Randomized controlled trial · cited 209 times

    PMID 22151630 · DOI 10.1111/j.1525-1403.2006.00055.x · Human clinical research

  4. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.

    JAMA · January 1, 2004 · Randomized controlled trial · cited 654 times

    PMID 14709577 · DOI 10.1001/jama.291.1.63 · Human clinical research

  5. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.

    Regional anesthesia and pain medicine · May 1, 2000 · Randomized controlled trial · cited 133 times

    PMID 10834782 · DOI 10.1016/s1098-7339(00)90010-5 · Human clinical research

  6. Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans.

    Journal of cardiovascular pharmacology · September 1, 1997 · Randomized controlled trial · cited 82 times

    PMID 9300326 · DOI 10.1097/00005344-199709000-00019 · Human clinical research

  7. Can Ziconotide Be Used to Replace Opioids? Exploratory Clinical Experience in 5 Patients Treated in the Pain Unit.

    Journal of pain research · September 17, 2025 · Other clinical trial · cited 1 times · open access

    PMID 40985013 · DOI 10.2147/jpr.s528946 · Human clinical research

  8. SPIDOL study protocol for the assessment of intrathecal ziconotide antalgic efficacy for severe refractory neuropathic pain due to spinal cord lesions.

    Trials · September 7, 2024 · Other clinical trial · cited 4 times · open access

    PMID 39244617 · DOI 10.1186/s13063-024-08387-0 · Human clinical research

  9. Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing.

    World neurosurgery · October 20, 2020 · Other clinical trial · cited 9 times

    PMID 33096281 · DOI 10.1016/j.wneu.2020.10.079 · Human clinical research

  10. Intracerebroventricular Pain Treatment with Analgesic Mixtures including Ziconotide for Intractable Pain.

    Pain physician · July 1, 2016 · Other clinical trial · cited 8 times

    PMID 27454282 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.

    JAMA · January 1, 2004 · Randomized controlled trial · cited 654 times

    PMID 14709577 · DOI 10.1001/jama.291.1.63 · Human clinical research

  2. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.

    Current medicinal chemistry · December 1, 2004 · Review · cited 608 times

    PMID 15578997 · DOI 10.2174/0929867043363884 · Reviews and meta-analyses

  3. Ziconotide for treatment of severe chronic pain.

    Lancet (London, England) · April 21, 2010 · Review · cited 356 times

    PMID 20413151 · DOI 10.1016/s0140-6736(10)60354-6 · Reviews and meta-analyses

  4. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom.

    Biochemistry · April 1, 1987 · Animal study · cited 343 times

    PMID 2441741 · DOI 10.1021/bi00382a004 · Animal studies

  5. Ziconotide: a review of its pharmacology and use in the treatment of pain.

    Neuropsychiatric disease and treatment · February 1, 2007 · Review · cited 311 times · open access

    PMID 19300539 · DOI 10.2147/nedt.2007.3.1.69 · Reviews and meta-analyses

Latest publications

  1. Resolving conformational polymorphism in disulfide-rich peptide drugs.

    Frontiers in chemistry · August 17, 2026 · In vitro study · cited 0 times · open access

    PMID 42676398 · DOI 10.3389/fchem.2026.1913741 · In vitro studies

  2. Intrathecal Ziconotide Long-Term Management in Chronic Postamputation Pain.

    Case reports in anesthesiology · August 2, 2026 · Case report · cited 0 times · open access

    PMID 42548796 · DOI 10.1155/cria/9977830 · Human clinical research

  3. A magnetic polymer adsorbent based on porous polystyrene microspheres for efficient extraction of conotoxins in biological fluids.

    The Analyst · July 27, 2026 · Animal study · cited 0 times

    PMID 42304757 · DOI 10.1039/d6an00324a · Animal studies

  4. Targeting Ca<sub>v</sub>2.2 channels for pain management: challenges, innovations, and future perspectives.

    Biochemical pharmacology · June 26, 2026 · Review · cited 1 times · open access

    PMID 42361918 · DOI 10.1016/j.bcp.2026.118199 · Reviews and meta-analyses

  5. A targeted partial reduction cyanylation strategy coupled with HRMS for accurate disulfide bridge mapping in disulfide rich cyclic peptides.

    Journal of chromatography. A · June 1, 2026 · In vitro study · cited 0 times

    PMID 42242129 · DOI 10.1016/j.chroma.2026.467160 · In vitro studies

  6. Real-Life Data on Ziconotide-Based Intrathecal Therapy in Patients With Cancer Pain: Interim Analysis of the Observational Practice in Clinics Registry.

    Neuromodulation : journal of the International Neuromodulation Society · April 21, 2026 · Observational human study · cited 1 times

    PMID 42189020 · DOI 10.1016/j.neurom.2026.04.006 · Human clinical research

  7. Functional crosstalk between neuropeptide FF system and N-type voltage-gated calcium channels in ziconotide-mediated antinociception in mice.

    Psychopharmacology · March 30, 2026 · Animal study · cited 1 times

    PMID 41910723 · DOI 10.1007/s00213-026-07053-4 · Animal studies

  8. Efficacy and safety of the Ca<sub>v</sub>2.2 blocker Ziconotide in pain: a meta-analysis and systematic review.

    Pain reports · November 14, 2025 · Review · cited 0 times · open access

    PMID 41255849 · DOI 10.1097/pr9.0000000000001363 · Reviews and meta-analyses

  9. Ziconotide as an Opioid Rescue: Economic, Clinical, and Subgroup Considerations [Letter].

    Journal of pain research · November 7, 2025 · Editorial, letter or other · cited 0 times · open access

    PMID 41229894 · DOI 10.2147/jpr.s571927 · Commentary and other

  10. Can Ziconotide Be Used to Replace Opioids? Exploratory Clinical Experience in 5 Patients Treated in the Pain Unit.

    Journal of pain research · September 17, 2025 · Other clinical trial · cited 1 times · open access

    PMID 40985013 · DOI 10.2147/jpr.s528946 · Human clinical research

Browse all 380 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Omega-conotoxin MVIIA; Prialt; SNX-111; Ziconotida; Ziconotide

((TITLE_ABS:"Omega-conotoxin MVIIA" OR CHEM:"Omega-conotoxin MVIIA") OR (TITLE_ABS:"Prialt" OR CHEM:"Prialt") OR (TITLE_ABS:"SNX-111" OR CHEM:"SNX-111" OR TITLE_ABS:"SNX111" OR CHEM:"SNX111") OR (TITLE_ABS:"Ziconotida" OR CHEM:"Ziconotida") OR (TITLE_ABS:"Ziconotide" OR CHEM:"Ziconotide")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 2). Ziconotide research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ziconotide